ARTA
TRAW icon

A.R.T. Advisors’s Traws Pharma TRAW Stock Holding History

A.R.T. Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44
Closed -$16K – 48
2021
Q1 		$16K Buy
+44
New +$16.6K 0.09% 51
2016
Q1 		– Sell
-1
Closed -$28K – 1692
2015
Q4 		$28K Buy
+1
New +$74.1K ﹤0.01% 1404
2015
Q1 		– Hold
0
– -$59K – 1735
2014
Q4 		– Sell
-1
Closed -$245K – 1336
2014
Q3 		$124K Hold
1
– – 0.01% 1182
2014
Q2 		$351K Sell
1
-1
-50% -$295K 0.02% 926
2014
Q1 		$747K Buy
2
+1
+100% +$602K 0.04% 607
2013
Q4 		$490K Buy
+1
New +$947K 0.03% 775

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

A.R.T. Advisors's TRAW Position: Q2 2021 in Review

A.R.T. Advisors sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 44 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in TRAW in Q4 2013 and held it in 6 quarters. The position peaked at $747K in Q1 2014. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

  • A.R.T. Advisors reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 44 Traws Pharma shares in Q2 2021, an estimated $16K.
  • A.R.T. Advisors first reported a position in Traws Pharma in Q4 2013 and held it in 6 quarters.
  • A.R.T. Advisors's Traws Pharma position peaked at $747K in Q1 2014.
  • 25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on A.R.T. Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.